Clinical Trials Sponsored by Akston Biosciences Corporation

Total 812 results

Boston Scientific Corporation

Completed

SpyGlass AMEA Registry

Biliary Stricture | Periampullary Tumor | Biliary Obstruction Due to Common Bile Duct Stone | Hemobilia

Hong Kong, Korea, Republic of, Thailand, Australia, Saudi Arabia, Japan, India, Pakistan, Singapore, South Africa
Boston Scientific Corporation

Completed

Cardiac Monitor Employee Study (CARMEL)

Arrhythmias, Cardiac

United States
Boston Scientific Corporation

Completed

PLATINUM Diversity

Coronary Artery Disease | Atherosclerosis

United States
Boston Scientific Corporation

Completed

Quadripolar CRT-D On Currently Approved Lead SystemS (CROSS X4)

Heart Failure

United States
Boston Scientific Corporation

Completed

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Coronary Artery Disease

United States, Spain, Denmark, Belgium, New Zealand, Australia, France, Italy, Canada, Singapore, Netherlands, Japan, Austria, Finland, Poland, Latvia
Boston Scientific Corporation

Terminated

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System (REPRISE EDGE)

Aortic Valve Stenosis

Sweden, Denmark, France
Boston Scientific Corporation

Completed

REPRISE Next Generation Delivery System (NGDS)

Aortic Stenosis

Australia
Boston Scientific Corporation

Completed

Asthma Intervention Research 2 (AIR2) Trial

Asthma

United States, United Kingdom, Australia, Brazil, Canada, Denmark, Netherlands
Boston Scientific Corporation

Terminated

Low Energy Therapy to Convert Ventricular Tachycardias (LEVER)

Ventricular Tachycardia

Australia
Boston Scientific Corporation

Completed

Safety and Performance Study of the Reliance 4-Front Lead

Tachycardia

Germany, United Kingdom, Italy, China, Israel, Sweden, Austria, Denmark, France, Portugal, Spain
Boston Scientific Corporation

Terminated

APPROPRIATE - Rate Adaptive Pacing Sensor (APPROPRIATE)

Heart Diseases

United States
Boston Scientific Corporation

Completed

The EASYTRAK EPI Clinical Investigation (EASYTRAK EPI)

Bradycardia | Congestive Heart Failure

United States
Boston Scientific Corporation

Completed

LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients

Bradycardia
Boston Scientific Corporation

Completed

Safety and Efficacy of CryoCor™ Cryoablation for PAF

Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

S-ICD® System IDE Clinical Study

Tachycardia, Ventricular

United States, Netherlands, New Zealand, United Kingdom
Boston Scientific Corporation

Completed

Short Term Pancreatic Stenting Registry

Post-ERCP Acute Pancreatitis | Pancreatic Duct Stricture | Pancreatic Duct Stones | Pancreatic Duct Leakage

United States, Netherlands, Germany, India
Boston Scientific Corporation

Completed

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

Coronary Artery Disease

Italy
Boston Scientific Corporation

Completed

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III) (PAPIRUSIII)

Heart Failure

Germany
Boston Scientific Corporation

Completed

ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients

Heart Failure | Long QT Syndrome | Wide QRS Complexes | Cardiac Resynchronisation

United Kingdom
Boston Scientific Corporation

Completed

First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data (FACTS)

Atrial Fibrillation | Ventricular Fibrillation | Ventricular Tachycardia

United States, Netherlands
Boston Scientific Corporation

Completed

Detection of Phrenic Nerve Stimulation Using Sensors' Signals (DETECT PS)

Heart Failure

Germany
Boston Scientific Corporation

Completed

Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents (ProEnCy)

Percutaneous Coronary Intervention

Germany
Boston Scientific Corporation

Completed

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

Coronary Artery Disease

Spain, Belgium, France, Australia, United Kingdom, Sweden, New Zealand, Denmark, Poland
Boston Scientific Corporation

Completed

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma (MIRACLE I)

Hepatocellular Carcinoma

Germany
Boston Scientific Corporation

Completed

INGENIO MRI/ FINELINE II Pacing System Data Collection in Patients Undergoing MRI (INFINITE-MRI)

Bradycardia

Netherlands
Boston Scientific Corporation

Completed

ION US Post-Approval Study

Coronary Artery Disease | Atherosclerosis

United States
Boston Scientific Corporation

Terminated

Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation

Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

PACMAN - PAcing for CardioMyopathies, a EuropeAN Study

Heart Failure

Belgium, Germany
Boston Scientific Corporation

Completed

Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter (REDUCE-HTN)

Hypertension

Australia, Germany, New Zealand, France, Netherlands, Belgium, Austria, Switzerland
Boston Scientific Corporation

Completed

Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System

Cardiovascular Diseases

New Zealand, France, Germany
Boston Scientific Corporation

Completed

Registry of AngioJet Use in the Peripheral Vascular System (PEARLII)

Embolism and Thrombosis | Venous Thrombosis | Peripheral Vascular Disease

United States, Canada, Italy, Germany, Slovakia
Boston Scientific Corporation

Completed

A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

Thrombosis | Peripheral Vascular Diseases | Venous Thrombosis
Boston Scientific Corporation

Completed

AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction

Myocardial Infarction

Italy
Boston Scientific Corporation

Completed

The OMEGA Clinical Trial

Coronary Artery Disease | Atherosclerosis

Belgium, United States, France, Germany, Latvia, Netherlands, Spain
Boston Scientific Corporation

Completed

Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH) (BEACH)

Stroke | Carotid Artery Diseases | Cerebral Arteriosclerosis

United States
Boston Scientific Corporation

Completed

RAPID-RF: Remote Active Monitoring in Patients With Heart Failure

Heart Failure

United States
Boston Scientific Corporation

Completed

WallFlex Biliary Post Liver Transplant IDE Pilot

Anastomotic Biliary Stricture Post Orthotopic Liver Transplant

United States
Boston Scientific Corporation

Completed

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Overactive Bladder

United States
Boston Scientific Corporation

Completed

ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0 (ELEVATE 3)

Heart Failure

United States
Boston Scientific Corporation

Completed

Evaluation of Left Ventricular Autothreshold, Phase Two (ELEVATE 2)

Heart Failure

United States
Boston Scientific Corporation

Completed

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) (PLATINUM QCA)

Coronary Artery Disease | Atherosclerosis

Australia, New Zealand, Malaysia, Singapore
Boston Scientific Corporation

Withdrawn

Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy

Pain | Chronic Pain | Complex Regional Pain Syndrome
Boston Scientific Corporation

Completed

A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels

Coronary Artery Disease

United States, Singapore, New Zealand
Boston Scientific Corporation

Completed

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Coronary Artery Disease

Canada, United States, Australia, Singapore, Taiwan, New Zealand, China
Boston Scientific Corporation

Completed

PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy (PEGASUS CRT)

Heart Failure

United States
Boston Scientific Corporation

Completed

SITELINE 2 Polyurethane

Bradycardia

United States
Boston Scientific Corporation

Completed

A Carotid Stenting Boston Scientific Surveillance Program (CABANA)

Carotid Artery Disease

United States
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis (TAXUS V ISR)

Coronary Restenosis

United States, Canada
Boston Scientific Corporation

Completed

A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Cholestasis, Extrahepatic

United States
Boston Scientific Corporation

Completed

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

Symptomatic Ischemic Saphenous Vein Graft Disease

United States, Canada

Clinical Trials Sponsored by Akston Biosciences Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations